Variant report
Variant | esv33446 |
---|---|
Chromosome Location | chr6:23891311-23916811 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142575847 | chr6:23891339-23891340 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372475490 | chr6:23891356-23891357 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576477031 | chr6:23891359-23891360 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs55877597 | chr6:23891362-23891363 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs55820117 | chr6:23891363-23891364 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577187722 | chr6:23891364-23891365 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577261213 | chr6:23891365-23891366 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558863292 | chr6:23891366-23891367 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10498714 | chr6:23891378-23891379 | Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs376301828 | chr6:23891414-23891415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369101041 | chr6:23891419-23891420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556742536 | chr6:23891427-23891428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374187508 | chr6:23891435-23891436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186280500 | chr6:23891436-23891437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190570446 | chr6:23891437-23891438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541095523 | chr6:23891446-23891447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs35720985 | chr6:23891504-23891505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533332004 | chr6:23891560-23891561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150922856 | chr6:23891565-23891566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs78446797 | chr6:23891579-23891580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs377130890 | chr6:23891582-23891583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115505169 | chr6:23891584-23891585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181446995 | chr6:23891613-23891614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567276706 | chr6:23891614-23891615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116836885 | chr6:23891679-23891680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552755936 | chr6:23891684-23891685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570916863 | chr6:23891687-23891688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141487308 | chr6:23891717-23891718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529945780 | chr6:23891749-23891750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538203829 | chr6:23891777-23891778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558079123 | chr6:23891779-23891780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576321124 | chr6:23891789-23891790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543690409 | chr6:23891811-23891812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545133177 | chr6:23891822-23891823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555907388 | chr6:23891830-23891831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557950451 | chr6:23891850-23891851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574124434 | chr6:23891866-23891867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1355460 | chr6:23891874-23891875 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs559845687 | chr6:23891877-23891878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533411625 | chr6:23891886-23891887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545410630 | chr6:23891911-23891912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149674257 | chr6:23891960-23891961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs34025762 | chr6:23891976-23891977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146634947 | chr6:23892015-23892016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540008746 | chr6:23892017-23892018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115590451 | chr6:23892046-23892047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs141469538 | chr6:23892057-23892058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145087317 | chr6:23892062-23892063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546680258 | chr6:23892080-23892081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561559157 | chr6:23892113-23892114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Uveal melanoma | 20484589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:23890600-23891400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr6:23890800-23893400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr6:23893400-23893800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr6:23904600-23905200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr6:23904600-23906200 | Enhancers | Primary hematopoietic stem cells | blood |
6 | chr6:23904800-23905400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr6:23904800-23906400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr6:23905000-23905400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr6:23905200-23905800 | Flanking Active TSS | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr6:23905400-23905800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr6:23905400-23905800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr6:23905600-23906000 | Enhancers | Colon Smooth Muscle | Colon |
13 | chr6:23905800-23906200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr6:23905800-23906200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr6:23905800-23906200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr6:23906200-23910800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr6:23910800-23911600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr6:23911600-23916000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr6:23915600-23916400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
20 | chr6:23915800-23916400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
21 | chr6:23915800-23917000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
22 | chr6:23916000-23916400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |